4.0 Article

No change in [11C]CUMI-101 binding to 5-HT1A receptors after intravenous citalopram in human

期刊

SYNAPSE
卷 66, 期 10, 页码 880-884

出版社

WILEY
DOI: 10.1002/syn.21579

关键词

5-HT1A; [11C]CUMI-101; citalopram; human; PET

资金

  1. Lundbeck Foundation
  2. Danish Council for Independent Research I Humanities

向作者/读者索取更多资源

The main objective of this study was to determine the sensitivity of [11C]CUMI-101 to citalopram challenge aiming at increasing extracellular 5-HT. CUMI-101 has agonistic properties in human embryonic kidney 293 cells transfected with human recombinant 5-HT1A receptors (Hendry et al. [2011] Nucl Med Biol 38:273277; Kumar et al. [2006] J Med Chem 49:125134) and has previously been demonstrated to be sensitive to bolus citalopram in monkeys (Milak et al. [2011] J Cereb Blood Flow Metab 31:243249). We studied six healthy individuals. Two PET-scans were performed on the same day in each individual before and after constant infusion of citalopram (0.15 mg/kg). The imaging data were analyzed using two tissue compartment kinetic modeling with metabolite corrected arterial input and Simplified Reference Tissue Modeling using cerebellum as a reference region. There was no significant difference in regional distribution volume or non-displaceable binding potential values before and after citalopram infusion. The mean receptor occupancy was 0.03 (range -0.14 to 0.17). Our data imply that [11C]CUMI-101 binding is not sensitive to citalopram infusion in humans. Synapse, 2012. (c) 2012 Wiley Periodicals, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Neuronal underpinnings of cognitive impairment in bipolar disorder: A large data-driven functional magnetic resonance imaging study

Jeff Zarp Petersen, Cristina Varo, Cecilie F. Skovsen, Caroline V. Ott, Hanne L. Kjaerstad, Eduard Vieta, Catherine J. Harmer, Gitte M. Knudsen, Lars V. Kessing, Julian Macoveanu, Kamilla W. Miskowiak

Summary: Cognitive impairment in bipolar disorder originates from the failure to recruit key regions in the cognitive control network (CCN) and to suppress task-irrelevant default mode network (DMN) activity during cognitive performance.

BIPOLAR DISORDERS (2022)

Article Clinical Neurology

Automated ictal EEG source imaging: A retrospective, blinded clinical validation study

Amir G. Baroumand, Anca A. Arbune, Gregor Strobbe, Vincent Keereman, Lars H. Pinborg, Martin Fabricius, Guido Rubboli, Camilla Gobel Madsen, Bo Jespersen, Jannick Brennum, Otto Molby Henriksen, Pieter van Mierlo, Sandor Beniczky

Summary: This study presents the clinical validation of an automated EEG source imaging (ESI) for seizure EEG signals. The results show that the automated ESI has a high accuracy for localizing the seizure onset zone, which can facilitate its implementation in the presurgical evaluation.

CLINICAL NEUROPHYSIOLOGY (2022)

Article Clinical Neurology

Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial

Messoud Ashina, Michel Lanteri-Minet, Patricia Pozo-Rosich, Anders Ettrup, Cecilie Laurberg Christoffersen, Mette Krog Josiassen, Ravinder Phul, Bjorn Sperling

Summary: This study investigated the safety and efficacy of eptinezumab for patients with migraine and two-to-four previous preventive treatment failures, showing significant migraine preventive effects compared to placebo.

LANCET NEUROLOGY (2022)

Article Clinical Neurology

Shift in diagnostic classification of migraine after initiation of preventive treatment with eptinezumab: post hoc analysis of the PROMISE studies

Patricia Pozo-Rosich, David W. Dodick, Anders Ettrup, Joe Hirman, Roger Cady

Summary: This post hoc analysis found that treatment with eptinezumab can reduce headache frequency and improve diagnostic category in migraine patients participating in the PROMISE clinical trials. This has important implications for reducing personal and societal burden.

BMC NEUROLOGY (2022)

Article Biochemistry & Molecular Biology

Characterization of the Novel P2X7 Receptor Radioligand [3H]JNJ-64413739 in Human Brain Tissue

Jens D. Mikkelsen, Sanjay S. Aripaka, Sif Kaad, Burcu A. Pazarlar, Lars Pinborg, Bente Finsen, Andrea Varrone, Benny Bang-Andersen, Jesper F. Bastlund

Summary: A newly developed radioligand [JNJ-64413739] that selectively binds to the purinergic receptor P2X7R has been found to detect neuroinflammation in the brain. The binding properties of JNJ-64413739 in human brain tissue were investigated, and it was found to have different binding abilities in gray and white matter. These findings demonstrate that JNJ-64413739 is suitable for evaluating the distribution and expression of P2X7R in the human brain.

ACS CHEMICAL NEUROSCIENCE (2023)

Article Clinical Neurology

Eptinezumab improved patient-reported outcomes and quality of life in patients with migraine and prior preventive treatment failures

Peter J. Goadsby, Piero Barbanti, Giorgio Lambru, Anders Ettrup, Cecilie Laurberg Christoffersen, Mette Krog Josiassen, Ravinder Phul, Bjorn Sperling

Summary: In a clinical trial, eptinezumab showed significant improvements in patient health and quality of life compared to placebo.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Article Endocrinology & Metabolism

Kinetic models for estimating occupancy from single-scan PET displacement studies

Gjertrud Louise Laurell, Pontus Plaven-Sigray, Annette Johansen, Nakul Ravi Raval, Arafat Nasser, Clara Aabye Madsen, Jacob Madsen, Hanne Demant Hansen, Lene Lundgaard Donovan, Gitte Moos Knudsen, Adriaan A. Lammertsma, R. Todd Ogden, Claus Svarer, Martin Schain

Summary: The traditional design of PET target engagement studies involves baseline scan and subsequent scans after drug administration. Researchers propose an alternative design, the displacement study, where the drug is administered during an ongoing scan, resulting in reduced radiation exposure and costs. They develop kinetic models to analyze PET displacement data, modifying existing compartment models to accommodate time-variant increase in occupancy. Through simulations and application to PET data from pigs, the proposed models show promise in estimating target occupancy from a single displacement scan.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2023)

Article Medicine, General & Internal

Single-Voxel MR Spectroscopy of Gliomas with s-LASER at 7T

Martin Prener, Giske Opheim, Zahra Shams, Christian Baastrup Sondergaard, Ulrich Lindberg, Henrik B. W. Larsson, Morten Ziebell, Vibeke Andree Larsen, Mark Bitsch Vestergaard, Olaf B. Paulson

Summary: In this exploratory study, the potential clinical implication of using single-voxel MRS at 7T to assess metabolic information on lesions in patients with grade II and III gliomas was evaluated. The findings showed significant changes in various metabolic ratios in glioma patients compared to healthy controls, as well as the presence of 2-HG. Evaluating metabolic information of gliomas is of significant importance in clinical practice.

DIAGNOSTICS (2023)

Article Medicine, General & Internal

Delineation of Grade II and III Gliomas Investigated by 7T MRI: An Inter-Observer Pilot Study

Martin Prener, Giske Opheim, Helle Juhl Simonsen, Christina Malling Engelmann, Morten Ziebell, Jonathan Carlsen, Olaf B. Paulson

Summary: This study aimed to compare the gross tumor volume (GTV) in 7T and 3T MRI scans of diffuse low-grade gliomas (DLGGs). The results showed that GTVs delineated from 7T images were smaller, and increasing the field strength improved inter-observer agreement only on the FLAIR sequence.

DIAGNOSTICS (2023)

Article Pharmacology & Pharmacy

Pharmacokinetics and Safety of Eptinezumab in Healthy Chinese Participants: A Randomized Clinical Trial

Xue-Ning Li, Hong-Rong Xu, Ellen Cui, Kamilla Buchberg Petersen, Janka Ryding, Anders Ettrup, Jette Buch Ostergaard, Frank Larsen

Summary: The pharmacokinetic profile of eptinezumab in healthy Chinese individuals was found to be similar to non-Asian populations with migraine. Eptinezumab was well tolerated in Chinese patients, with no new safety concerns identified. Evaluation of immunogenicity showed no impact of anti-drug antibodies or neutralizing antibodies on safety profiles, supporting the approved doses of 100 mg and 300 mg for Chinese patients with episodic or chronic migraine.

CLINICAL DRUG INVESTIGATION (2023)

Article Clinical Neurology

Text mining of electronic health records can validate a register-based diagnosis of epilepsy and subgroup into focal and generalized epilepsy

Siri A. Vulpius, Sebastian Werge, Isabella Friis Jorgensen, Troels Siggaard, Jorge Hernansanz Biel, Gitte M. Knudsen, Soren Brunak, Lars H. Pinborg

Summary: This study demonstrates that text mining of clinical notes can improve the accuracy of epilepsy diagnosis and classification of different epilepsy types for patients. It suggests that combining population-based health registries with electronic health records can be crucial for future precision medicine development for epilepsy patients.

EPILEPSIA (2023)

Article Clinical Neurology

Ictal and interictal SPECT with Tc-99m-HMPAO in presurgical epilepsy. I: Predictive value and methodological considerations

Martin Prener, Veronica Drejer, Morten Ziebell, Per Jensen, Camilla Gobel Madsen, Svitlana Olsen, Gerda Thomsen, Lars H. H. Pinborg, Olaf B. B. Paulson

Summary: This retrospective study investigates the predictive value of ictal subtraction single-photon emission computed tomography (SPECT) co-registered to magnetic resonance imaging (MRI) (SISCOM) for successful epilepsy surgery. The results showed that the positive predictive value for good surgical outcome was 74.1% and 40% for different seizure durations.

EPILEPSIA OPEN (2023)

Article Clinical Neurology

Ictal and interictal SPECT with 99mTc-HMPAO in presurgical epilepsy. II: Methodological considerations on hyper- and hypoperfusion

Martin Prener, Veronica Drejer, Morten Ziebell, Per Jensen, Camilla Gobel Madsen, Svitlana Olsen, Gerda Thomsen, Lars H. Pinborg, Olaf B. Paulson

Summary: Reversed SISCOM performed better than conventional SISCOM at predicting good surgical outcomes. In approximately half of the cases, reversed SISCOM added additional value by either altering or confirming the conclusion. Sensitivity, positive predictive value (PPV), and odds ratio were better in the subgroup with longer seizure durations after injection (>30 s) and worse in the group with shorter durations (<30 s).

EPILEPSIA OPEN (2023)

Article Clinical Neurology

Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures: post hoc analysis of the DELIVER randomized clinical trial

Messoud Ashina, Richard B. Lipton, Jessica Ailani, Jan Versijpt, Simona Sacco, Dimos D. Mitsikostas, Cecilie Laurberg Christoffersen, Bjorn Sperling, Anders Ettrup

Summary: This post hoc analysis suggests that eptinezumab can reduce monthly migraine days in patients with difficult-to-treat migraines. The majority of patients who responded to eptinezumab during the initial weeks maintained or improved their response during the later weeks. Additionally, a significant number of initial non-responders showed a response after the second infusion.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Article Neurosciences

Accuracy of high-density EEG electrode position measurement using an optical scanner compared with the photogrammetry method

Orsolya Gyorfi, Cheng-Teng Ip, Anders Bach Justesen, Maria Louise Gam-Jensen, Connie Romer, Martin Fabricius, Lars H. Pinborg, Sandor Beniczky

Summary: This study aimed to evaluate the accuracy and feasibility of a handheld optical scanner for measuring high-density EEG electrode coordinates. The results showed that the optical scanner had a lower mean distance error compared to the photogrammetry method, and the real-time scanning time was shorter. The handheld optical scanner is suitable for EEG source imaging in the clinical setting.

CLINICAL NEUROPHYSIOLOGY PRACTICE (2022)

Article Neurosciences

Corticotropin-releasing factor-dopamine interactions in male and female macaque: Beyond the classic VTA

E. A. Kelly, T. M. Love, J. L. Fudge

Summary: Dopamine is involved in stress-related illnesses, and corticotropin-releasing factor plays a role in stress responses. This study examined the synaptic terminals between dopamine and non-dopamine cells and found that dopamine regulation may occur indirectly through contacts with non-dopamine neurons.

SYNAPSE (2024)